Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Apo-Modafinil |
Active Ingredient: | Modafinil 100mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Apotex NZ Limited |
Manufacturer: | Apotex Inc, Toronto, Canada |
Product: | Pemetrexed Accord |
Active Ingredient: | Pemetrexed disodium hemipentahydrate 110.29mg equivalent to pemetrexed 100mg |
Dosage Form: | Powder for infusion |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
Product: | Pemetrexed Accord |
Active Ingredient: | Pemetrexed disodium hemipentahydrate 551.45mg equivalent to pemetrexed 500mg |
Dosage Form: | Powder for infusion |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
Product: | Pemetrexed Accord |
Active Ingredient: | Pemetrexed disodium hemipentahydrate 1102.9mg equivalent to pemetrexed 1000mg |
Dosage Form: | Powder for infusion |
New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
Dated this 17th day of January 2020.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).